**Strong opening momentum and horror genre tailwinds have anchored trader consensus around a $150-160 million domestic finish by October 31.** The Zach Cregger-directed reboot debuted to a franchise-best $60 million in mid-September, fueled by a 96% Rotten Tomatoes score, B+ CinemaScore, and robust Thursday previews of $8.8 million that exceeded earlier $40-50 million tracking. This performance reflects broad audience interest in the R-rated survival horror premise and Cregger’s proven horror credentials following *Weapons* and *Barbarian*. However, steep second-weekend drops typical of the genre, combined with a $75 million production budget and front-loaded theatrical run, have tempered upside expectations. Current totals near $110 million leave roughly four weeks for the film to add the remaining legs needed for the leading bracket, with limited competition and sustained word-of-mouth as the main swing factors before the October 31 cutoff.